| Year |
Citation |
Score |
| 2023 |
Tatineni V, O'Shea PJ, Saxena S, Khosla AA, Ozair A, Kotecha RR, Jia X, Rauf Y, Murphy ES, Chao ST, Suh JH, Peereboom DM, Ahluwalia MS. Combination of EGFR-Directed Tyrosine Kinase Inhibitors (EGFR-TKI) with Radiotherapy in Brain Metastases from Non-Small Cell Lung Cancer: A 2010-2019 Retrospective Cohort Study. Cancers. 15. PMID 37296975 DOI: 10.3390/cancers15113015 |
0.635 |
|
| 2023 |
Tatineni V, O'Shea PJ, Ozair A, Khosla AA, Saxena S, Rauf Y, Jia X, Murphy ES, Chao ST, Suh JH, Peereboom DM, Ahluwalia MS. First- versus Third-Generation EGFR Tyrosine Kinase Inhibitors in EGFR-Mutated Non-Small Cell Lung Cancer Patients with Brain Metastases. Cancers. 15. PMID 37190312 DOI: 10.3390/cancers15082382 |
0.638 |
|
| 2023 |
Ozair A, Kumar A, Subash NR, Mirza S, Khosla AA, Ahluwalia M, Dahm P. Authorship Diversity in Global Evidence Synthesis in Urology: 1998-2022 Analysis of Cochrane Reviews. Bju International. PMID 36951507 DOI: 10.1111/bju.16010 |
0.634 |
|
| 2023 |
Ozair A, Bhat V, Alisch RS, Khosla AA, Kotecha RR, Odia Y, McDermott MW, Ahluwalia MS. DNA Methylation and Histone Modification in Low-Grade Gliomas: Current Understanding and Potential Clinical Targets. Cancers. 15. PMID 36831683 DOI: 10.3390/cancers15041342 |
0.654 |
|
| 2023 |
Kotecha R, Odia Y, Khosla AA, Ahluwalia MS. Key Clinical Principles in the Management of Glioblastoma. Jco Oncology Practice. OP2200476. PMID 36638331 DOI: 10.1200/OP.22.00476 |
0.568 |
|
| 2022 |
Khosla AA, Saxena S, Ozair A, Venur VA, Peereboom DM, Ahluwalia MS. Novel Therapeutic Approaches in Neoplastic Meningitis. Cancers. 15. PMID 36612116 DOI: 10.3390/cancers15010119 |
0.657 |
|
| 2022 |
Singh K, Saxena S, Khosla AA, McDermott MW, Kotecha RR, Ahluwalia MS. Update on the Management of Brain Metastasis. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. PMID 36422836 DOI: 10.1007/s13311-022-01312-w |
0.545 |
|
| Show low-probability matches. |